Javascript must be enabled to continue!
Effects of Tongxinluo capsule on homocysteine-induced endothelial dysfuncion and inflammartoy response
View through CrossRef
Objective
To investigate the effects of Tongxinluo (TXL) on Homocysteine (HCY)-induced endothelial dysfunction and inflammatory response.
Methods
Isolation, culture and identification of human umbilical vein endothelial cells (HUVECs): With the informed consent of puerperants, the normal fetal umbilical cords were obtained through uterine-incision delivery in Third Affiliated Hospital, Sun Yat-sun University. HUVECs were isolated by Percoll density gradient centrifugation from fetal umbilical cords with digestion of collagenase type I perfusion, and then suspended in Medium 199 cultured in 0.05 volume fraction of CO2 incubator at 37°C. After the HUVECs were identified by flow cytometry with the cell marker CD34, The second or third passage was used for study. MTT assay was used to detect cell viability: HUVECs during the logarithmic phase were inoculated in 96-well plates with Medium 199 in 0.05 volume fraction of CO2 incubator at 37°C for 48 h, at 80% confluence, incubated in serum-free medium, and divided into two groups, each group including eight parallel wells, blank control group was untreated, the latter cultured and added with HCY of the concentrations of 0.1, 0.25, 0.5, and 1.0 mmol/l, respectively, or HCY 0.5 mmol/l+TXL of the concentrations of 0.1, 0.5, 1.0, and 2.0 mg/ml. After the cells were cultured for 24 h, 5 g/l MTT solution (20 μl) was added, then dimethyl sulfoxide was used for vibration and dissolvement. Optical density of each hole was detected by using enzyme-linked immunosorbent assay to analyse different concentrations of HCY and TXL on the proliferation of human mammary stems cells. Western blot was used to examine the protein expression of the cell inflammatory factors, tumour necrosis factor (TNF)α, interleukin (IL)-6, macrophage chemoattractant protein (MCP)-1, and intercellular adhesion molecule (ICAM)-1, ELISA was used to detect the contents of the cell inflammatory factors.
Results
HCY of different doses inhibited the viability of HUVECs dose-dependently, the inhibition rates of HCY were 0.099±0.079, 0.239±0.046, 0.637±0.007, and 0.553±0.029, respectively (all p<0.01); the growth rates of HCY-induced HUVECs treatment by TXL of the concentrations of 0.1, 0.5, 1.0, and 2.0 mg/ml were 0.682±0.312, 0.710±0.040, 0.855±0.130, 0.784±0.031, respectively, higher than that of the control group (all p<0.01). Western blotting and ELISA showed that homocysteine significantly increased the expression of TNFα, IL-6, MCP-1 and ICAM-1, which are 0.71±0.15, 0.89±0.32, 0.80±0.27, 0.54±012, respectively, higher than that of 0 hour (all p<0.01). However, the expression levels of TNFα, IL-6, MCP-1 and ICAM-1 of the 0.50 mmol/l HCY-induced HUVECs treatment by TXL (1 mg/ml) were 0.24±0.04, 0.15±0.03, 0.13±0.04, 0.22±0.06, respectively, not significantly different from those at the of 0 hour (all p>0.01).
Conclusion
Tongxinluo inhibits homocysteine-induced endothelial impairment and inflammatory response, the definite mechanism of which requires further research.
Title: Effects of Tongxinluo capsule on homocysteine-induced endothelial dysfuncion and inflammartoy response
Description:
Objective
To investigate the effects of Tongxinluo (TXL) on Homocysteine (HCY)-induced endothelial dysfunction and inflammatory response.
Methods
Isolation, culture and identification of human umbilical vein endothelial cells (HUVECs): With the informed consent of puerperants, the normal fetal umbilical cords were obtained through uterine-incision delivery in Third Affiliated Hospital, Sun Yat-sun University.
HUVECs were isolated by Percoll density gradient centrifugation from fetal umbilical cords with digestion of collagenase type I perfusion, and then suspended in Medium 199 cultured in 0.
05 volume fraction of CO2 incubator at 37°C.
After the HUVECs were identified by flow cytometry with the cell marker CD34, The second or third passage was used for study.
MTT assay was used to detect cell viability: HUVECs during the logarithmic phase were inoculated in 96-well plates with Medium 199 in 0.
05 volume fraction of CO2 incubator at 37°C for 48 h, at 80% confluence, incubated in serum-free medium, and divided into two groups, each group including eight parallel wells, blank control group was untreated, the latter cultured and added with HCY of the concentrations of 0.
1, 0.
25, 0.
5, and 1.
0 mmol/l, respectively, or HCY 0.
5 mmol/l+TXL of the concentrations of 0.
1, 0.
5, 1.
0, and 2.
0 mg/ml.
After the cells were cultured for 24 h, 5 g/l MTT solution (20 μl) was added, then dimethyl sulfoxide was used for vibration and dissolvement.
Optical density of each hole was detected by using enzyme-linked immunosorbent assay to analyse different concentrations of HCY and TXL on the proliferation of human mammary stems cells.
Western blot was used to examine the protein expression of the cell inflammatory factors, tumour necrosis factor (TNF)α, interleukin (IL)-6, macrophage chemoattractant protein (MCP)-1, and intercellular adhesion molecule (ICAM)-1, ELISA was used to detect the contents of the cell inflammatory factors.
Results
HCY of different doses inhibited the viability of HUVECs dose-dependently, the inhibition rates of HCY were 0.
099±0.
079, 0.
239±0.
046, 0.
637±0.
007, and 0.
553±0.
029, respectively (all p<0.
01); the growth rates of HCY-induced HUVECs treatment by TXL of the concentrations of 0.
1, 0.
5, 1.
0, and 2.
0 mg/ml were 0.
682±0.
312, 0.
710±0.
040, 0.
855±0.
130, 0.
784±0.
031, respectively, higher than that of the control group (all p<0.
01).
Western blotting and ELISA showed that homocysteine significantly increased the expression of TNFα, IL-6, MCP-1 and ICAM-1, which are 0.
71±0.
15, 0.
89±0.
32, 0.
80±0.
27, 0.
54±012, respectively, higher than that of 0 hour (all p<0.
01).
However, the expression levels of TNFα, IL-6, MCP-1 and ICAM-1 of the 0.
50 mmol/l HCY-induced HUVECs treatment by TXL (1 mg/ml) were 0.
24±0.
04, 0.
15±0.
03, 0.
13±0.
04, 0.
22±0.
06, respectively, not significantly different from those at the of 0 hour (all p>0.
01).
Conclusion
Tongxinluo inhibits homocysteine-induced endothelial impairment and inflammatory response, the definite mechanism of which requires further research.
Related Results
e0332 Tongxinluo capsule for coronary heart disease: a systematic review
e0332 Tongxinluo capsule for coronary heart disease: a systematic review
Objective
To assess the effectiveness and safety of tongxinluo capsule for coronary heart disease.
Methods
...
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
Objectives
To detect the effect of Sini Decoction on the expression of Sirt-1 and eNOS in EAhy926 cell injured by homocysteine.
...
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
Objectives
To detect the effect of Sini Decoction on the expression of Caveolin-1 and eNOS in EAhy926 cell injured by homocysteine.
...
Inhibitory effect of capsule on natural transformation of Streptococcus pneumoniae
Inhibitory effect of capsule on natural transformation of Streptococcus pneumoniae
ABSTRACT
The capsule ofStreptococcus pneumoniae(Spn) is highly heterogeneous based on expression of distinct polysaccharides.Spntransformation, controlled by the Com regulon, has b...
Susceptibility towards Irradiation-Induced Bone Marrow (BM) Dysplasia in Vivo Is Determined by the BM Vasculogenic Phenotype: Correlation with MDS Patients BM Samples
Susceptibility towards Irradiation-Induced Bone Marrow (BM) Dysplasia in Vivo Is Determined by the BM Vasculogenic Phenotype: Correlation with MDS Patients BM Samples
Abstract
Bone marrow (BM) endothelial cells regulate hematopoiesis by promoting mobilization, survival and proliferation of hematopoietic progenitors. Interfering wi...
Homocysteine and vitamins in cardiovascular disease
Homocysteine and vitamins in cardiovascular disease
AbstractOn the basis of recent retrospective and prospective studies, it is now widely accepted that increased total plasma homocysteine is a risk factor for cardiovascular disease...
Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction
Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction
Abstract
Background: Moderate hyperhomocysteinemia is considered a risk factor for thrombosis and atherosclerosis. We hypothesized that higher maternal and newborn h...
No effect of homocysteine‐lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease
No effect of homocysteine‐lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease
AbstractBackground Although peripheral arterial occlusive disease (PAOD) is significantly associated with elevated homocysteine levels, the clinical relevance of hyperhomocysteina...

